Bicycle Therapeutics plc (BCYC) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bicycle Therapeutics (BCYC) PT Lowered to $55 at Oppenheimer
March 1, 2023 1:21 PM ESTOppenheimer analyst Jay Olson lowered the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $55.00 (from $65.00) while maintaining an Outperform rating.
The analyst commented, "BCYC reported 4Q financial results with $24.7M R&D and $10.7M G&A expenses, totaling a quarterly net... More
